SCHEMBL6037841

SCHEMBL6037841

O=C(O)Cc1cccc(OCCCC(S)C(=O)O)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G4B P0C869 2/20 0.54
CYP4F2 P78329 1/20 0.49
CYP4A11 Q02928 1/20 0.49
NR1H3 Q13133 3/20 0.48
PPARD Q03181 1/20 0.46
MAPK1 P28482 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
PTPN11 Q06124 1/20 0.45
LTB4R Q15722 1/20 0.44
TSHR P16473 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
NR1H2 P55055 2/20 0.43
MEN1 O00255 1/20 0.43
NR1I2 O75469 1/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPT P10636 1/20 0.43
RXRA P19793 1/20 0.43
VHL P40337 1/20 0.43
RECQL P46063 1/20 0.43
BLM P54132 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30278815 0.85 PLA2G4B (0.68) PLA2G4BCYP4F2CYP4A11NR1H3PPARD
SCHEMBL25081990 0.85 PLA2G4B (0.68) PLA2G4BCYP4F2CYP4A11NR1H3PPARD
SCHEMBL30278807 0.85 PLA2G4B (0.64) PLA2G4BCYP4F2CYP4A11NR1H3PPARD
SCHEMBL25081989 0.85 PLA2G4B (0.64) PLA2G4BCYP4F2CYP4A11NR1H3PPARD
SCHEMBL25081993 0.84 PLA2G4B (0.71) PLA2G4BCYP4F2CYP4A11NR1H3PPARD
SCHEMBL25081988 0.84 PLA2G4B (0.71) PLA2G4BCYP4F2CYP4A11NR1H3PPARD
SCHEMBL30278812 0.84 PLA2G4B (0.71) PLA2G4BCYP4F2CYP4A11NR1H3PPARD
SCHEMBL25081987 0.84 PLA2G4B (0.71) PLA2G4BCYP4F2CYP4A11NR1H3PPARD
SCHEMBL30278806 0.84 PLA2G4B (0.71) PLA2G4BCYP4F2CYP4A11NR1H3PPARD
SCHEMBL25081992 0.83 PLA2G4B (0.62) PLA2G4BCYP4F2CYP4A11NR1H3PPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002057222-A9 THIOL-BASED NAALADASE INHIBITORS GUILFORD PHARM INC (US) 2004-05-06 WO claimed
EP-1353903-A2 THIOL-BASED NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 2003-10-22 EP claimed
WO-2002057222-A2 THIOL-BASED NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 2002-07-25 WO claimed
WO-2006093991-A1 COMPOUNDS WHICH BIND PSMA AND USES THEREOF THE CLEVELAND CLINIC FOUNDATION (US) 2006-09-08 WO disclosed